Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market

Benign Prostatic
Hyperplasia (BPH) And
Prostate Treatment
Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016-2026
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Benign prostatic hyperplasia (BPH) is also known as benign prostatic hypertrophy or benign
prostatic obstruction. Benign prostatic hyperplasia (BPH) is a health condition in men in
which the prostate gland size is enlarged than a normal. In a men whole life, prostate grows
in two phases, first phase is occurs in early stage of puberty, second phase starts at the age of
twenty five and it continues most of persons life. BPH occurs in second phase of growth and
it is very general problem in a men who are above age 50. In 2010, 14 Mn men in the U.S.
diagnosed with BPH. However, BPH may occurs in before age 40 and the chances of BPH will
increase with age.
If prostate gland enlarges than its normal size, the gland presses in between pinches and the
urethra. As a result, the bladder wall become thicker and lose the ability to empty the
bladder completely. Symptoms of BPH include urinary frequency, nocturia and urinary
incontinence. BPH may causes urinary tract infections, bladder damage, and kidney damage
in an acute stage.
To treat BPH, medications, minimally invasive procedures and surgeries are available.
Medications are used to shrink the prostate gland and reduce the symptoms of BPH,
minimally invasive procedures and surgeries performed when medication is ineffective.
Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Drivers and Restraints
Benign Prostatic Hyperplasia (BPH) treatment market driven by increasing ageing population
around world. Increasing incidence rates of BPH also expected to drive the overall benign
prostatic hyperplasia market.Availability of different treatment procedures to treat benign
prostatic hyperplasia and prostate treatment also expected to drive the BPH market during
Report
Description
Report Description
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/repgb-1664
Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Segmentation
Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market is segmented into
following types
By Treatment
•Medication
• Alpha blockers
• Phosphodiesterase-5 inhibitors
• Combination medications
•Minimally invasive surgeries
• Transurethral Needle Ablation
• Transurethral Microwave Thermotherapy
• High-Intensity Focused Ultrasound
• Transurethral Electrovaporization
• Water-Induced Thermotherapy
• Prostatic Stent Insertion
•Surgeries
Report
Description
Report Description
By End User
•Hospitals
•Ambulatory Surgery Centers
•Hospital Pharmacies
•Retail Stores
Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Overview
Increasing healthcare awareness among mass population along with rise in prevalence rate of
benign prostatic hyperplasia (BPH) is expected to propel the overall demand for (BPH) and
prostate treatment market. The market is expected to witness a healthy growth over the
forecast period (2016-2026)
Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Region- wise OutlooK
Depending on geographic regions, the global benign prostatic hyperplasia (BPH) and prostate
treatment market is segmented into seven key regions: North America, Latin America, Eastern
Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.
BPH market is mainly depend on the ageing population. Among all regions, Europe and Asia
Pacific are expected to witness a high growth rate over the forecast period owing to the large
number of ageing population in these regions. North America and Latin America also expected
to witness a healthy growth rate during the forecast period.
Report
Description
Report Description
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1664
Benign Prostatic Hyperplasia (BPH) and Prostate Treatment Market: Key Players
•Some of the key players in this market are
•Sanofi Aventis
•Sandoz Inc
•Watson Laboratories Inc
•Labopharm Inc
•Teva Pharmaceuticals Usa Inc
•Pfizer Inc
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705